Assessment of Potential Acetylcholinesterase Inhibitors: An In Silico Study

Background: In the spectrum of neurodegenerative conditions, Alzheimer disease (AD) stands out as the predominant contributor to dementia and behavioral alterations. Cholinesterase inhibitors (ChE-Is) represent the primary pharmaceutical category currently endorsed for addressing AD.  Objectives: Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Nathaniel Ohiemi Amedu, Michael Olim Obu
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2024-08-01
Series:Pharmaceutical and Biomedical Research
Subjects:
Online Access:http://pbr.mazums.ac.ir/article-1-619-en.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!